1) US Department of Health and Human Service. Cigar, 1998
|
|
|
2) Doz E, Noulin N, Boichot E, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R/MyD88 signaling dependent. J Immunol. 2008; 180: 1169-78
|
|
|
3) Pace E, Ferraro M, Siena L, et al. Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology. 2008; 124: 401-11
|
|
|
4) Kang MJ, Lee CG, Lee JY, et al. Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and re-modeling responses in mice. J Clin Invest. 2008; 118: 2771-84
|
|
|
5) Maes T, Bracke KR, Vermaelen KY, et al. Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol. 2006; 141: 354-68
|
|
|
6) Kitamura M, Kasai A. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Lett. 2007; 252: 184-94
|
|
|
7) Kawajiri K, Fujii-Kuriyama Y. Cytochrome P450 gene regulation and physiological functions mediated by the arylhydrocarbon receptor. Arch Biochem Biophys. 2007; 464: 207-12
|
|
|
8) Kasai A, Hiramatsu K, Hayakawa J, et al. High levels of dioxin-like potential in cigarette smoke evidenced by in vitro and in vivo biosensing. Cancer Res. 2006; 66: 7143-50
|
|
|
9) Culpitt SV, Rogers DF, Fenwick PS, et al. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax. 2003; 58: 942-6
|
|
|
10) Demedts IK, Bracke KR, Van Pottelberge G, et al. Accumulation of dendric cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 175: 998-1005
|
|
|
11) Tsoumakidou M, Demedts IK, Brusselle GG, et al. Dendric cells in chronic obstructive pulmonary disease. New players in an old game. Am J Respir Crit Care Med. 2008; 177: 1180-6
|
|
|
12) Tsuji T, Aoshiba K, Nagai A. Cigarette smoke induces senescence in alveolar epithelial cells. Am J Respir Cell Mol Biol. 2004; 31: 643-9
|
|
|
13) Yao H, Yang S, Edirisinghe I, et al. Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice. Am J Respir Cell Mol Biol. 2008; 39: 7-18
|
|
|
14) Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in pulmonary emphysema patients. Am J Respir Crit Care Med. 2006; 174: 886-93
|
|
|
15) Tuder RM, Yun JH, Graham BB. Cigarette smoke triggers code red. p21CIP1/WAF1/SD1 switches on danger responses in the lung. Am J Respir Cell Mol Biol. 2008; 39: 1-6
|
|
|
16) Greaves L, Richardson LA. Tobacco use, women, gender, and chronic obstructive pulmonary disease. Are the connections being adequetely made? Proc Am Thorc Soc. 2007; 4: 675-9
|
|
|
17) Cohen SB, Pare PD, Man SFP, et al. The growing burden of chronic obstructive pulmonary disease and lung cancer in women. Examining sex differences in cigarette smoke metabolism. A J Respir Crit Care Med. 2007; 136: 113-20
|
|
|
18) Sin DD, Cohen B, Day A, et al. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc. 2007; 4: 671-4
|
|
|
19) 根本信雄. たばこ煙中のがん原物質代謝と代謝酵素の発現調節. 喫煙科学研究の歩み. 1996年から2005年. 喫煙科学研究財団. 2007年2月
|
|
|
20) Zhang JY, Wang Y, Prakash C. Xenobiotic-metabolizing enzymes in human lung. Curr Drug Metab. 2006; 7: 939-48
|
|
|
21) Chang H, Chang LW, Cheng YH, et al. Preferential induction of CYP1A1 and CYP1B1 in CCSP-positive cells. Toxicol Sci. 2006; 89: 205-13
|
|
|
22) Mollerup S, Ryberg D, Hewer A, et al. Sex differences in lung CYP1A1 expression and DNA adducts levels among lung cancer patients. Cancer Res. 1999; 59: 3317-20
|
|
|
23) Al Koudsi N, Mwenifumbo JC, Sellers EM, et al. Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics. Eur J Clini Pharmacol. 2006; 62: 481-4
|
|
|
24) Han W, Pentecost BT, Pietropaoko RL et al. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog. 2005; 44: 202-11
|
|
|
25) Ganti AK, Sahmoun AE, Panwalker AW, et al. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol. 2006; 24: 59-63
|
|
|